#USA #Melbourne #Health Equity #preeclampsia #HELLP Syndrome

Application for 2026 Vision Grant Opens

In a significant move towards advancing research on pregnancy-related disorders, the Preeclampsia Foundation along with its Canadian counterpart, Preeclampsia Foundation Canada, has announced the opening of applications for its 2026 Vision Grant funding program. This initiative, which aims to support groundbreaking research in the field, will focus on critical health inequities and conditions such as HELLP syndrome.

Focus Areas of the Grant

The 2026 Vision Grant will feature four distinct research grants, with the primary emphasis on health equity. Two grants, each offering up to $20,000 USD, will be awarded in the United States specifically focusing on preeclampsia and associated hypertensive disorders, seeking to address disparities in health outcomes. Similarly, the Preeclampsia Foundation Canada will issue two grants, one dedicated to HELLP syndrome with a ceiling of $25,000 CAD, while another will shed light on preeclampsia within Black Canadian populations, also promising up to $20,000 CAD.

According to Eleni Tsigas, CEO of the Preeclampsia Foundation, “Black and Indigenous women in North America encounter higher rates of hypertensive disorders during pregnancy, along with more severe outcomes.” By directing funding towards research that concentrates on impacted groups, the Foundation aims to enhance the body of knowledge regarding these conditions and improve patient outcomes through increased representation in clinical research.

Eligibility Criteria and Application Process

The Vision Grants are designed to provide initial funding to innovative and promising research initiatives led by early-career scientists, including post-doctoral fellows and clinical researchers. To qualify, applicants must propose projects that analyze health equity, illustrating how their work will contribute to improving clinical outcomes for underserved communities, including Black and Indigenous populations. Additionally, these studies must incorporate participant enrollment strategies involving the Preeclampsia Registry, thus promoting greater understanding of these vital issues.

International researchers are encouraged to apply, though submissions must be in English. It’s noteworthy that the Canadian Vision Grant aimed at health equity has been named the Maya B. Dash Vision Grant, acknowledging the support received from the Doane Grant Thornton Foundation. This specific grant is exclusively available to Canadian researchers.

Another grant concentrated on HELLP syndrome research will welcome applications from all qualifying researchers, backed by the Cara HELLPs research fund that honors Cara Kernohan, who tragically lost her life to the syndrome while pregnant.

Application Deadline and Further Information

Interested parties will need to submit their applications by May 27, 2026, with grant award notifications expected in September 2026. Detailed eligibility criteria and application procedures can be found on their respective websites: Preeclampsia Foundation for the U.S. applications and Preeclampsia Foundation Canada for Canadian submissions.

Conclusion

The Vision Grant program represents a significant effort by the Preeclampsia Foundation to foster innovative research and address dire health disparities in maternal health. With over half a million dollars already invested in pioneering research since its inception, it continues to encourage young investigators to develop new concepts that may aid in unraveling the complexities of conditions that have perplexed the medical community for centuries. As such, this initiative not only aims to catalyze new discoveries but also strives to improve health equity in pregnancy outcomes for various communities facing systemic barriers in healthcare access and quality.